Tests umbilical cord stem cells in people with hepatitis B liver cirrhosis
Tests donor umbilical cord stem cells in adults with liver scarring caused by hepatitis B.
Plain-language title generated from the registry record
Registry title: Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
Key facts
- Where
- Jakarta, IndonesiaSee the site
- Phase
- Phase 1/2
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT04357600, who can take part
Where in Indonesia
- Cipto Mangunkusumo hospitalJakarta, IndonesiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- PT. Prodia Stem Cell Indonesia
- Trial code
- NCT04357600
- Record updated
- 25 February 2026
- Original description
The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.Read full original descriptionShow less
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study
The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
Inclusion: Patients with decompensated cirrhosis (Child-Pugh B) caused by hepatitis B infection (Cirrhosis is evidenced by the results of ultrasonography examination and chronic hepatitis B infection is found in patients who are taking hepatitis B drugs).
Exclusion: Patients who have undergone transplantation and other stem cell therapy; Having malignancies disease, both liver malignancies or other malignancies; Having another co-infections such as hepatitis C and Human Immunodeficiency Virus (HIV); Having complications disease such as diabetes mellitus, severe heart disease, kidney disease, and respiratory disease; Patients who refuse to participate in research; Pregnant or lactation patients as evidenced by positive pregnancy test results; Having the case of alcohol dependence and NASH.